Trial intelligence / Profile preview

MCC-135 in Congestive Heart Failure

NCT00050076Phase 2Completed

Sponsor
Takeda
Start
Aug 2002
Primary completion
Aug 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Caldaret in heart failure (HF), sponsored by Takeda. Started Aug 2002; status: completed.

02

Drugs

Caldaret
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00050076.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00050076.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call